7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Li G et al. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. 2015 Int J Clin Exp Pathol pmid:26884838
Li B et al. Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. 2015 Genet. Mol. Res. pmid:26782591
Schiro A et al. Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. 2015 Sci Rep pmid:26564003
Mizuno M et al. Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. 2015 Sci Rep pmid:26561427
Morisawa T et al. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. 2015 Int Heart J pmid:26549398
Beuselinck B et al. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. 2015 Br. J. Cancer pmid:26528707
Rewiuk K and Grodzicki T Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. 2015 Biomed Res Int pmid:26504794
Pesce Viglietti AI et al. Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. 2015 Infect. Immun. pmid:26459511
Nemeth ZK et al. Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. 2015 Sci Rep pmid:26459001
Zhang HL and Jin X Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity. 2015 Genet. Mol. Res. pmid:26400332
Ren H et al. Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. 2015 Mol Med Rep pmid:26398911
Wang J et al. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. 2015 PLoS ONE pmid:26218592
Kao SY and Stankovic KM Transactivation of human osteoprotegerin promoter by GATA-3. 2015 Sci Rep pmid:26216189
Kassem A et al. TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. 2015 FASEB J. pmid:26207027
Yang H et al. A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. 2015 Int J Clin Exp Pathol pmid:26191212
Pitari MR et al. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. 2015 Oncotarget pmid:26160841
Hsu BG et al. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. 2015 Tohoku J. Exp. Med. pmid:26156285
Miao X et al. Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. 2015 J Orthop Surg Res pmid:26148858
Bartosińska J et al. The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. 2015 Mediators Inflamm. pmid:26146462
Ye XH et al. Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. 2015 Genet. Mol. Res. pmid:26125863
Yu SG et al. Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. 2015 Int J Clin Exp Pathol pmid:26097549
Schmitz F et al. Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. 2015 Cell Metab. pmid:26094892
Kondegowda NG et al. Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. 2015 Cell Metab. pmid:26094891
Ardeshirpour L et al. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. 2015 Endocrinology pmid:25961842
Reveille JD Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. 2015 Clin. Rheumatol. pmid:25939520
Bortolin RH et al. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. 2015 PLoS ONE pmid:25933189
Wei J et al. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. 2015 Mol Med Rep pmid:25891179
Su F et al. Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. 2015 Stem Cell Res Ther pmid:25888745
Shen Y et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. 2015 BMC Complement Altern Med pmid:25887296
Duan P et al. Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. 2015 BMC Womens Health pmid:25884698
Warren JT et al. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. 2015 J. Cell. Biochem. pmid:25864714
Kim KR et al. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. 2015 PLoS ONE pmid:25859665
Wu C et al. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. 2015 Genes Dev. pmid:25846796
Åšwierkot J et al. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. 2015 Arch. Immunol. Ther. Exp. (Warsz.) pmid:25837853
Hassan SH et al. Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. 2015 Dis. Markers pmid:25814780
Dale MD et al. Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. 2015 Int J Mol Sci pmid:25625518
Ottewell PD et al. OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. 2015 Int. J. Cancer pmid:25603921
Son GY et al. Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. 2015 J. Dent. Res. pmid:25595364
Oostra DR et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. 2015 Mol. Cell. Endocrinol. pmid:25575458
Majerczyk M et al. [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. 2015 Postepy Hig Med Dosw (Online) pmid:27259222
Fu Y et al. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. 2015 J. Vet. Sci. pmid:25549213
Lin TH et al. NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. 2015 Tissue Eng Part A pmid:25518013
Kadlub N et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. 2015 J. Bone Miner. Res. pmid:25491283
Recker EN et al. A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. 2015 J. Periodontol. pmid:25269523
Meijome TE et al. GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. 2015 J. Cell. Physiol. pmid:25205203
Solberg LB et al. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. 2015 Histochem. Cell Biol. pmid:25201349
Hung JY et al. Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. 2015 Int. J. Oncol. pmid:25738754
Nash LA et al. Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. 2015 Mol Nutr Food Res pmid:25488131
Kelesidis T et al. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. 2014 Jul-Sep AIDS Rev pmid:25102334
Bastos MF et al. Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats. 2014 Jan-Feb Int J Oral Maxillofac Implants pmid:24451874
Guo L et al. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. 2014 DNA Cell Biol. pmid:24283361
Samara S et al. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. 2014 Exp. Mol. Pathol. pmid:24200492
Casarin RC et al. Resveratrol improves bone repair by modulation of bone morphogenetic proteins and osteopontin gene expression in rats. 2014 Int J Oral Maxillofac Surg pmid:24530035
Puato M et al. Impact of hypertension on vascular remodeling in patients with psoriatic arthritis. 2014 J Hum Hypertens pmid:23842084
Lim WH et al. Downregulation of Wnt causes root resorption. 2014 Am J Orthod Dentofacial Orthop pmid:25172256
Jiang Y et al. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. 2014 J Transl Med pmid:25471933
Titanji K et al. Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. 2014 PLoS Pathog. pmid:25393853
Akiyama N et al. Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. 2014 J. Exp. Med. pmid:25385757
Lv Y et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. 2014 BMC Musculoskelet Disord pmid:25377946
D'Abramo A et al. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. 2014 Mediators Inflamm. pmid:25374442
Samir SM and Malek HA Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. 2014 J. Physiol. Pharmacol. pmid:25371528
Arrigoni C et al. Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. 2014 Mol. Cancer pmid:25335447
Zhang X et al. Ultrastructural characterization of the implant interface response to loading. 2014 J. Dent. Res. pmid:24389808
Lv Z et al. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. 2014 Oncol. Rep. pmid:24337584
Cardelli M and Aubin JE ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. 2014 PLoS ONE pmid:25313644
Kim JY et al. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. 2014 Biol. Pharm. Bull. pmid:24492722
Movérare-Skrtic S et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. 2014 Nat. Med. pmid:25306233
Hayashida C et al. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. 2014 J. Biol. Chem. pmid:24610813
Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. 2014 J. Vasc. Res. pmid:24642764
Wohlfahrt JC et al. Sulcus fluid bone marker levels and the outcome of surgical treatment of peri-implantitis. 2014 J. Clin. Periodontol. pmid:24417563
Park SY et al. Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. 2014 Toxicol. Appl. Pharmacol. pmid:24463094
Jasiewicz M et al. Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. 2014 Pol. Arch. Med. Wewn. pmid:25188298
Genre F et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. 2014 PLoS ONE pmid:25184828
Zhang YD et al. Association of the g.19074G>A genetic variant in the osteoprotegerin gene with bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:25177945
Bandeira F et al. Bone markers and osteoporosis therapy. 2014 Arq Bras Endocrinol Metabol pmid:25166041
Foo JP et al. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. 2014 J. Clin. Endocrinol. Metab. pmid:25148234
Warren JT et al. Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members. 2014 Sci Signal pmid:25140055
Yan D et al. Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. 2014 J Orthop Surg Res pmid:25138985
Schieferdecker A et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. 2014 Oncotarget pmid:25138051
Chung SL et al. Low-magnitude high-frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats. 2014 J. Orthop. Res. pmid:25131218
Yoshida S et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA Observational Cohort Study. 2014 PLoS ONE pmid:25105978
Li T et al. Rabbiteye blueberry prevents osteoporosis in ovariectomized rats. 2014 J Orthop Surg Res pmid:25102951
Kim YH et al. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. 2014 Biomaterials pmid:24125774
Ohlsson C et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. 2014 PLoS ONE pmid:24637895
Loureiro MB et al. Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes. 2014 Diabetes Res. Clin. Pract. pmid:24529565
Tera Tde M et al. The RANK/ RANKL/ OPG interaction in the repair of autogenous bone grafts in female rats with estrogen deficiency. 2014 Braz Oral Res pmid:25229791
Huang C et al. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro. 2014 Biomed Mater pmid:24518283
Milanova V et al. TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice. 2014 Mediators Inflamm. pmid:24757287
Nolen BM et al. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 2014 PLoS ONE pmid:24747429
Zhao JJ et al. Association analysis between the OPG g.27667T>A genetic variant and bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:24737508
Yoo YM et al. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. 2014 Int J Mol Sci pmid:24717410
Deng L et al. Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. 2014 Lipids Health Dis pmid:24712339
Chung PL et al. Effect of age on regulation of human osteoclast differentiation. 2014 J. Cell. Biochem. pmid:24700654
Sirjani M et al. The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. 2014 Iran J Allergy Asthma Immunol pmid:24659160
Wang JH et al. Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. 2014 J Clin Hypertens (Greenwich) pmid:24640954
Liu YP et al. Association of the g.27563G>A osteoprotegerin genetic polymorphism with bone mineral density in Chinese women. 2014 Genet. Mol. Res. pmid:24615112
Ovchinnikova OA et al. The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions. 2014 J. Intern. Med. pmid:24588843
Montes de Oca A et al. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. 2014 PLoS ONE pmid:24586847
Guo L et al. Effects of erythropoietin on osteoblast proliferation and function. 2014 Clin. Exp. Med. pmid:23135151
Ostrowska Z et al. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa. 2014 Endokrynol Pol pmid:24549600

Table of Content